Publications related to Organoruthenium chemistry

Synthesis, Structure, and Anticancer Activity of Arene-Ruthenium(II) Complexes with Acylpyrazolones Bearing Aliphatic Groups in the Acyl Moiety

Paul Joseph Dyson, Rosario Scopelliti, Tina Riedel

A series of neutral ruthenium(II) arene complexes [(arene)Ru(Q(R))Cl] (arene = p-cymene (cym) or hexamethylbenzene (hmb)) containing 4-acyl-5-pyrazolonate Q(R) ligands with different electronic and steric substituents (R = 4-cyclohexyl, 4-stearoyl, or 4-ad ...

American Chemical Society2016

Nonsteroidal Anti-inflammatory-Organometallic Anticancer Compounds

Paul Joseph Dyson, Rosario Scopelliti, Mylène Soudani, Emilia Paunescu, Sarah Mcarthur

Compounds that combine metal-based drugs with covalently linked targeted organic agents have been shown, in some instances, to exhibit superior anticancer properties compared to the individual counterparts. Within this framework, we prepared a series of or ...

Amer Chemical Soc2016

Chiral Cyclopentadienyls: Enabling Ligands for Asymmetric Rh(III)-Catalyzed C-H Functionalizations

Nicolai Cramer, Baihua Ye

Transition-metal catalyzed C-H functionalizations became a complementary and efficient bond-forming strategy over the past decade. In this respect, Cp*Rh(III) complexes have emerged as powerful catalysts for a broad spectrum of reactions giving access to s ...

American Chemical Society2015

In vivo anti-tumor activity of the organometallic ruthenium(II)-arene complex [Ru(eta(6)-p-cymene)-Cl-2(pta)] (RAPTA-C) in human ovarian and colorectal carcinomas

Paul Joseph Dyson, Patrycja Nowak-Sliwinska, Maxime Dubois

Based on the clinical success of platinum-based anti-cancer drugs such as cisplatin, carboplatin and oxaliplatin, a variety of other metal-based anti-cancer compounds are being investigated. In particular, a number of ruthenium-based compounds have been id ...

2014

Potential of Cycloaddition Reactions To Generate Cytotoxic Metal Drugs In Vitro

Paul Joseph Dyson, Sviatlana Siankevich, Benjamin Samuel Murray, Stéphanie Crot

Severe general toxicity issues blight many chemotherapeutics utilized in the treatment of cancers, resulting in the need for more selective drugs able to exert their biological activity at only the required location(s). Toward this aim, we report the devel ...

Amer Chemical Soc2014

Cytotoxicity of ruthenium-arene complexes containing B-ketoamine ligands

Paul Joseph Dyson, Rosario Scopelliti, Catherine Marie Amélie Clavel

New ruthenium(II) arene derivatives (arene = p-cymene, benzene, hexamethylbenzene) containing beta-ketoamine ligands L' (HL' in general; in detail, HLph,ph = (4Z)-3-methyl-4-((phenylamino)(phenyl)methylene)-1-phenyl-1H-pyrazol-5(4H)-one, HLnaph,ph = (4Z)-3 ...

American Chemical Society2013

Synthesis, Characterization, and Reactivity of the First Osmium beta-Diketiminato Complexes and Application in Catalysis

Paul Joseph Dyson, Rosario Scopelliti, Andrew Douglas Phillips, Dominique Schreiber

The strongly chelating anionic beta-diketiminate ligand has been employed to formulate complexes involving almost every metal of the periodic table; however, the heavier metals of the d block remain relatively unexplored. This paper describes the synthesis ...

Amer Chemical Soc2013

Chiral Cyclopentadienyl Ligands as Stereocontrolling Element in Asymmetric C-H Functionalization

Nicolai Cramer, Baihua Ye

Metal complexes coordinated by a single cyclopentadienyl (Cp) ligand are widely used, versatile catalysts, but their application to asymmetric reactions has been hindered by the difficulty of designing Cp substituents that effectively bias the coordination ...

Amer Assoc Advancement Science2012

Enhanced rate of arene hydrogenation with imidazolium functionalized bipyridine stabilized rhodium nanoparticle catalysts

Paul Joseph Dyson, Rosario Scopelliti, Ning Yan, Ryan Dykeman

The imidazolium functionalized bipyridine compounds, {4,4'-bis-[7-(2,3-dimethylimidazolium)heptyl]-2,2'-bipyridine}(2+) (BIHB) and {4,4'-bis[(1,2-dimethylimidazolium)methyl]-2,2'-bipyridine}(2+) (BIMB), were prepared and used as Rh nanoparticle ...

2011

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Organoruthenium chemistry

Synthesis, Structure, and Anticancer Activity of Arene-Ruthenium(II) Complexes with Acylpyrazolones Bearing Aliphatic Groups in the Acyl Moiety

Nonsteroidal Anti-inflammatory-Organometallic Anticancer Compounds

Chiral Cyclopentadienyls: Enabling Ligands for Asymmetric Rh(III)-Catalyzed C-H Functionalizations

In vivo anti-tumor activity of the organometallic ruthenium(II)-arene complex [Ru(eta(6)-p-cymene)-Cl-2(pta)] (RAPTA-C) in human ovarian and colorectal carcinomas

Potential of Cycloaddition Reactions To Generate Cytotoxic Metal Drugs In Vitro

Syntheses and Catalytic Applications of Ruthenium Cyclopentadienyl Complexes

Cytotoxicity of ruthenium-arene complexes containing B-ketoamine ligands

Synthesis, Characterization, and Reactivity of the First Osmium beta-Diketiminato Complexes and Application in Catalysis

Chiral Cyclopentadienyl Ligands as Stereocontrolling Element in Asymmetric C-H Functionalization

Enhanced rate of arene hydrogenation with imidazolium functionalized bipyridine stabilized rhodium nanoparticle catalysts

Graph Chatbot

Chat with Graph Search

Potential of Cycloaddition Reactions To Generate Cytotoxic Metal Drugs In Vitro

Chiral Cyclopentadienyl Ligands as Stereocontrolling Element in Asymmetric C-H Functionalization

Synthesis, Structure, and Anticancer Activity of Arene-Ruthenium(II) Complexes with Acylpyrazolones Bearing Aliphatic Groups in the Acyl Moiety

Nonsteroidal Anti-inflammatory-Organometallic Anticancer Compounds

Syntheses and Catalytic Applications of Ruthenium Cyclopentadienyl Complexes

Chiral Cyclopentadienyls: Enabling Ligands for Asymmetric Rh(III)-Catalyzed C-H Functionalizations

In vivo anti-tumor activity of the organometallic ruthenium(II)-arene complex [Ru(eta(6)-p-cymene)-Cl-2(pta)] (RAPTA-C) in human ovarian and colorectal carcinomas

Cytotoxicity of ruthenium-arene complexes containing B-ketoamine ligands

Synthesis, Characterization, and Reactivity of the First Osmium beta-Diketiminato Complexes and Application in Catalysis

Enhanced rate of arene hydrogenation with imidazolium functionalized bipyridine stabilized rhodium nanoparticle catalysts